Some highly penetrant mutations have been identified (e.g., DNA mismatch repair genes, APC, SMAD4, LKB1/STK11, and MUTYH) that have a significant impact on CRC susceptibility, although they represent only 2–5% of CRC cases [2]. This evidence concerns the gene APC and colorectal carcinoma.